The next role of Linda Yaccarino after leaving X as CEO will play a different CEO role Emed Population HealthAn AI startup is building a technical platform for patients using GLP-1’s.
Yaccarino was an old advertisement -executive at NBCUIVERSALLE, but left for two years at X as a CEO as a CEO, where she succeeded in having a positive impact on the troubled advertising income model of the social network, despite the shared approach to her and Elon Musk to minimize content.
Although Yaccarino has no experience with Health Tech, EMED said in a press release that they were looking for her for her “unmistakable ability to negotiate new partnerships”-it certainly also helps that her term of office at X made her known in the technical world and pointed more eyes to the startup.
Medal earlier Produced a technical platform that was designed to be used with home COVID-19 Fast Antigen tests, where users are guided by the process of managing these tests. Now EMED is aimed at GLP-1’s, the class of medicines such as Ozempic, which can be used for both weight management and treatment of type 2 diabetes.
“To be a leader in the current health care market, companies must have a fearless tenacity that they can not only grow, but also to be brave enough to step forward and to define an entire industry,” Yaccarino said In a press release. “We are very well positioned to be that persistent leader, who strive for our ultimate goal of improving the worldwide results of health care through our groundbreaking services and platforms.”
#Linda #Yaccarino #joins #Health #Tech #Platform #Emed #Emed #leaving #Techcrunch